Modulation of adipose tissue lipolysis and body weight by high-density lipoproteins in mice

Nutrition and Diabetes

Volumn 4, Issue 2, 2014, Pages

  Wei, H ^a   Averill, M M ^a   McMillen, T S ^a   Dastvan, F ^a   Mitra, P ^a   Subramanian, S ^a   Tang, C ^a   Chait, A ^a   LeBoeuf, R C ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Caloric restriction; HDL; Hormone sensitive lipase; Mice; Obesity

Indexed keywords

APOLIPOPROTEIN A1; CATECHOLAMINE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE SENSITIVE LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA;

3T3 CELL LINE; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; CALORIC RESTRICTION; CELL CULTURE; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; DIET; ENERGY EXPENDITURE; ENZYME PHOSPHORYLATION; FAT MASS; FATTY ACID OXIDATION; FOOD INTAKE; GENOTYPE; LEAN BODY WEIGHT; LIPOLYSIS; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT GAIN; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

EID: 84919354745     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2014.4     Document Type: Article

References (50)

1. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008; 32: 1431-1437.
2. Malik VS, Willett WC, Hu FB. Global obesity: Trends, risk factors and policy implications. Nature reviews. Endocrinology 2013; 9: 13-27.
3. Organization WH. Global Health Risks. Mortality and Burden of Disease Attributable to Selected Major Risks. World Health Organization: Geneva, 2009.
4. Blecker S, Herbert R, Brancati FL. Comorbid diabetes and end-of-life expenditures among Medicare beneficiaries with heart failure. J Cardiac Failure 2012; 18: 41-46.
5. Ingelsson E, Sullivan LM, Murabito JM, Fox CS, Benjamin EJ, Polak JF et al. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes 2007; 56: 1718-1726.
6. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
7. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
8. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882-889.
9. Mooradian AD, Haas MJ, Wehmeier KR, Wong NC. Obesity-related changes in high-density lipoprotein metabolism. Obesity 2008; 16: 1152-1160.
10. Mureddu GF, Brandimarte F, De Luca L. High-density lipoprotein levels and risk of cardiovascular events: A review. J Card Med 2012; 13: 575-586.
11. Fisher EA, Feig JE, Hewing B, Hazen SL, Smith JD. High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arteriosclerosis Thrombosis Vasc Biol 2012; 32: 2813-2820.
12. Tang C, Oram JF. The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes. Biochimica et Biophysica Acta 2009; 1791: 563-572.
13. Sorci-Thomas MG, Thomas MJ. High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. Arteriosclerosis Thrombosis Vasc Biol 2012; 32: 2561-2565.
14. Umemoto THC, Mitra P, Averill MM, Tang C, Goodspeed L, Omer M et al. Apolipoprotein A-I and HDL have anti-inflammatory effects on adipocytes via cholesterol transporters; ATP-binding cassette (ABC) A-1, ABCG-1 and scavenger receptor B-1 (SRB-1). Circ Res 2013; 112: 1345-1354.
15. Zhu X, Parks JS. New roles of HDL in inflammation and hematopoiesis. Annu Rev Nutr 2012; 32: 161-182.
16. deGoma EM, deGoma RL, Rader DJ. Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J Am Coll Cardiol 2008; 51: 2199-2211.
17. Farkas J, Angel A, Avigan MI. Studies on the compartmentation of lipid in adipose cells. II. Cholesterol accumulation and distribution in adipose tissue components. J Lipid Res 1973; 14: 344-356.
18. Schreibman PH, Dell RB. Human adipocyte cholesterol. Concentration, localization, synthesis, and turnover. J Clin Invest 1975; 55: 986-993.
19. Yu BL, Zhao SP, Hu JR. Cholesterol imbalance in adipocytes: A possible mechanism of adipocytes dysfunction in obesity. Obes Rev 2010; 11: 560-567.
20. Seneff S, Wainwright G, Mascitelli L. Is the metabolic syndrome caused by a high fructose, and relatively low fat, low cholesterol diet? Arch Med Sci 2011; 7: 8-20.
21. Edgel KA, McMillen TS, Wei H, Pamir N, Houston BA, Caldwell MT et al. Obesity and weight loss result in increased adipose tissue ABCG1 expression in db/db mice. Biochimica et Biophysica Acta 2012; 1821: 425-434.
22. Prattes S, Horl G, Hammer A, Blaschitz A, Graier WF, Sattler W et al. Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: Triglyceride droplets are surrounded by cholesterol-rich ER-like surface layer structures. J Cell Sci 2000; 113(Pt 17): 2977-2989.
23. Ruan X, Li Z, Zhang Y, Yang L, Pan Y, Wang Z et al. Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat. J Cell Mol Med 2011; 15: 763-772.
24. Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, Ikehara S et al. L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice. J Lipid Res 2008; 49: 1658-1669.
25. Han R, Lai R, Ding Q, Wang Z, Luo X, Zhang Y et al. Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism. Diabetologia 2007; 50: 1960-1968.
26. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 2007; 117: 746-756.
27. Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest 1994; 94: 1698-1705.
28. Taicher GZ, Tinsley FC, Reiderman A, Heiman ML. Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Analytical Bioanalytical Chemistry 2003; 377: 990-1002.
29. Tinsley FC, Taicher GZ, Heiman ML. Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes Res 2004; 12: 150-160.
30. Pamir N, McMillen TS, Kaiyala KJ, Schwartz MW, LeBoeuf RC. Receptors for tumor necrosis factor-alpha play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology 2009; 150: 4124-4134.
31. Li H, Reddick RL, Maeda N. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. Arteriosclerosis Thrombosis 1993; 13: 1814-1821.
32. Ahmadian M, Wang Y, Sul HS. Lipolysis in adipocytes. Int J Biochem Cell Biol 2010; 42: 555-559.
33. Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 2006; 53: 482-491.
34. Bickel PE, Tansey JT, Welte MA. PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochimica et Biophysica Acta 2009; 1791: 419-440.
35. McIntosh AL, Storey SM, Atshaves BP. Intracellular lipid droplets contain dynamic pools of sphingomyelin: ADRP binds phospholipids with high affinity. Lipids 2010; 45: 465-477.
36. McManaman JL, Bales ES, Orlicky DJ, Jackman M, Maclean PS, Cain S et al. Perilipin-2 null mice are protected against diet-induced obesity, adipose inflammation and fatty liver disease. J Lipid Res 2013; 54: 1346-1359.
37. Bi J, Xiang Y, Chen H, Liu Z, Gronke S, Kuhnlein RP et al. Opposite and redundant roles of the two Drosophila perilipins in lipid mobilization. J Cell Sci 2012; 125(Pt 15): 3568-3577.
38. Shen WJ, Patel S, Miyoshi H, Greenberg AS, Kraemer FB. Functional interaction of hormone-sensitive lipase and perilipin in lipolysis. J Lipid Res 2009; 50: 2306-2313.
39. Rubin EM, Ishida BY, Clift SM, Krauss RM. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc Natl Acad Sci USA 1991; 88: 434-438.
40. Yue L, Mazzone T. Endogenous adipocyte apolipoprotein E is colocalized with caveolin at the adipocyte plasma membrane. J Lipid Res 2011; 52: 489-498.
41. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr 2007; 27: 79-101.
42. Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, Zechner R et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 2010; 120: 3466-3479.
43. Breen MR, Camps M, Carvalho-Simoes F, Zorzano A, Pilch PF. Cholesterol depletion in adipocytes causes caveolae collapse concomitant with proteosomal degradation of cavin-2 in a switch-like fashion. PloS One 2012; 7: e34516.
44. Fujimoto T, Kogo H, Ishiguro K, Tauchi K, Nomura R. Caveolin-2 is targeted to lipid droplets, a new 'membrane domain' in the cell. J Cell Biol 2001; 152: 1079-1085.
45. Verghese PB, Arrese EL, Soulages JL. Stimulation of lipolysis enhances the rate of cholesterol efflux to HDL in adipocytes. Mol Cell Biochem 2007; 302: 241-248.
46. Miura Y, Hanada K, Jones TL. G (s) signaling is intact after disruption of lipid rafts. Biochemistry 2001; 40: 15418-15423.
47. Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 2000; 275: 41447-41457.
48. Le Lay S, Robichon C, Le Liepvre X, Dagher G, Ferre P, Dugail I. Regulation of ABCA1 expression and cholesterol efflux during adipose differentiation of 3T3-L1 cells. J Lipid Res 2003; 44: 1499-1507.
49. Zhang Y, McGillicuddy FC, Hinkle CC, O'Neill S, Glick JM, Rothblat GH et al. Adipocyte modulation of high-density lipoprotein cholesterol. Circulation 2010; 121: 1347-1355.
50. Storey SM, McIntosh AL, Senthivinayagam S, Moon KC, Atshaves BP. The phospholipid monolayer associated with perilipin-enriched lipid droplets is a highly organized rigid membrane structure. Am J Physiol Endocrinol Metab 2011; 301: E991-E1003.